• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Diagnostic algorithm for the confirmation of cases of measles and rubella in Mexico.

作者信息

Román-Pedroza Juan Francisco, Cruz-Ramírez Edith, Landín-Martínez Kathia Elia, Salas-García Mónica, López-Ortiz Eduardo, Ramírez-González José Ernesto, López-Martínez Irma, Díaz-Quiñonez José Alberto

机构信息

Institute of Epidemiological Diagnosis and Reference "Dr. Manuel Martínez Báez" Mexico City, Mexico.

Universidad Nacional Autónoma de México, Faculty of Medicine, Postgraduate Studies Division. Mexico City, Mexico.

出版信息

Gac Med Mex. 2019;155(5):492-495. doi: 10.24875/GMM.M20000337.

DOI:10.24875/GMM.M20000337
PMID:32091024
Abstract

Due to the successful implementation of measles and rubella elimination strategies, Mexico announced the interruption of endemic transmission of measles in 1996 and that of rubella in 2008. After a verification process, the region of the Americas was declared free of rubella and congenital rubella syndrome in 2015 and of measles in 2016. In order to maintain the elimination status in Mexico, it is essential to continue laboratory surveillance within the framework of the Global Measles and Rubella Laboratory Network. The Institute of Epidemiological Diagnosis and Reference, through the National Network of Public Health Laboratories, guarantees timely and reliable results in view of the possible reintroduction of these and other emerging pathogens.

摘要

相似文献

1
Diagnostic algorithm for the confirmation of cases of measles and rubella in Mexico.
Gac Med Mex. 2019;155(5):492-495. doi: 10.24875/GMM.M20000337.
2
Algoritmo diagnóstico para la confirmación de casos de sarampión y rubéola en México.
Gac Med Mex. 2019;155(5):532-536. doi: 10.24875/GMM.19005497.
3
Global Measles and Rubella Laboratory Network Support for Elimination Goals, 2010-2015.全球麻疹和风疹实验室网络对消除目标的支持,2010-2015 年。
MMWR Morb Mortal Wkly Rep. 2016 May 6;65(17):438-42. doi: 10.15585/mmwr.mm6517a3.
4
Genetic Characterization of Measles and Rubella Viruses Detected Through Global Measles and Rubella Elimination Surveillance, 2016-2018.2016-2018 年全球麻疹和风疹消除监测中检出的麻疹和风疹病毒的遗传特征。
MMWR Morb Mortal Wkly Rep. 2019 Jul 5;68(26):587-591. doi: 10.15585/mmwr.mm6826a3.
5
Global measles and rubella laboratory network support for elimination goals, 2010–2015.2010 - 2015年全球麻疹和风疹实验室网络对消除目标的支持
Wkly Epidemiol Rec. 2016 May 6;91(18):240-6.
6
Guidelines for the documentation and verification of measles, rubella, and congenital rubella syndrome elimination in the region of the Americas.美洲地区消除麻疹、风疹和先天性风疹综合征的文件记录和核实准则。
J Infect Dis. 2011 Sep 1;204 Suppl 2:S683-9. doi: 10.1093/infdis/jir471.
7
Expansion of Surveillance for Vaccine-preventable Diseases: Building on the Global Polio Laboratory Network and the Global Measles and Rubella Laboratory Network Platforms.扩大疫苗可预防疾病监测:基于全球脊髓灰质炎实验室网络和全球麻疹和风疹实验室网络平台
J Infect Dis. 2017 Jul 1;216(suppl_1):S324-S330. doi: 10.1093/infdis/jix077.
8
Towards elimination of measles and rubella in Italy: Progress and challenges.迈向意大利消除麻疹和风疹的目标:进展与挑战。
PLoS One. 2019 Dec 16;14(12):e0226513. doi: 10.1371/journal.pone.0226513. eCollection 2019.
9
Challenges of measles and rubella laboratory diagnostic in the era of elimination.消除麻疹和风疹实验室诊断的挑战。
Clin Microbiol Infect. 2017 Aug;23(8):511-515. doi: 10.1016/j.cmi.2017.04.009. Epub 2017 Apr 13.
10
Global landscape of measles and rubella surveillance.全球麻疹和风疹监测概况。
Vaccine. 2018 Nov 19;36(48):7385-7392. doi: 10.1016/j.vaccine.2018.10.007. Epub 2018 Oct 11.

引用本文的文献

1
Measles and Rubella Diagnostic and Classification Challenges in Near- and Post-Elimination Countries.接近消除和已消除麻疹风疹国家中的麻疹和风疹诊断及分类挑战
Vaccines (Basel). 2024 Jun 20;12(6):697. doi: 10.3390/vaccines12060697.